All terms in HP
Label | Id | Description |
---|---|---|
Choroidal melanoma | HP_0012054 | [Malignant tumor of melanocytes of the choroid. The classic appearance of choroidal melanoma is a pigmented dome-shaped or collar button-shaped tumor with an associated exudative retinal detachment. Choroidal melanoma is usually pigmented, but can be variably pigmented and even amelanotic (non-pigmented).] |
Low serum calcifediol | HP_0012053 | [A reduced concentration of calcifediol in the blood. Calcifediol is also known as calcidiol, 25-hydroxycholecalciferol and 25-Hydroxyvitamin D3.] |
Low levels of vitamin D | HP_0100512 | [A reduced concentration of Vitamin D.] |
Low serum calcitriol | HP_0012052 | [A reduced concentration of calcitriol in the blood. Calcitriol is also known as 1,25-dihydroxycholecalciferol or 1,25-dihydroxyvitamin D3.] |
regulation of hydrolase activity | GO_0051336 | [Any process that modulates the frequency, rate or extent of hydrolase activity, the catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.] |
regulation of dephosphorylation | GO_0035303 | [Any process that modulates the frequency, rate or extent of removal of phosphate groups from a molecule.] |
Reactive hypoglycemia | HP_0012051 | [Hypoglycermia following a meal (or more generally, after intake of glucose).] |
Hypoglycemia | HP_0001943 | [A decreased concentration of glucose in the blood.] |
positive regulation of phosphatase activity | GO_0010922 | [Any process that increases the rate or frequency of phosphatase activity. Phosphatases catalyze the hydrolysis of phosphoric monoesters, releasing inorganic phosphate.] |
positive regulation of hydrolase activity | GO_0051345 | [Any process that activates or increases the frequency, rate or extent of hydrolase activity, the catalysis of the hydrolysis of various bonds.] |
positive regulation of dephosphorylation | GO_0035306 | [Any process that activates or increases the frequency, rate or extent of removal of phosphate groups from a molecule.] |
catalytic activity | GO_0003824 | [Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.] |
Renal hypoplasia | HP_0000089 | [Hypoplasia of the kidney.] |
Renal insufficiency | HP_0000083 | [A reduction in the level of performance of the kidneys in areas of function comprising the concentration of urine, removal of wastes, the maintenance of electrolyte balance, homeostasis of blood pressure, and calcium metabolism.] |
Horseshoe kidney | HP_0000085 | [A connection of the right and left kidney by an isthmus of functioning renal parenchyma or fibrous tissue that crosses the midline.] |
Abnormal localization of kidney | HP_0100542 | [An abnormal site of the kidney.] |
Duplicated collecting system | HP_0000081 | [A duplication of the collecting system of the kidney, defined as a kidney with two (instead of, normally, one) pyelocaliceal systems. The pyelocaliceal system is comprised of the renal pelvis and calices. The duplicated renal collecting system can be associated with a single ureter or with double ureters. In the latter case, the two ureters empty separately into the bladder or fuse to form a single ureteral orifice.] |
Keratan sulfate excretion in urine | HP_0012069 | [An increased concentration of keratan sulfate in the urine.] |
Aspartylglucosaminuria | HP_0012068 | [Excretion of excess amounts of aspartylglucosamine in the urine.] |
Glycopeptiduria | HP_0012067 | [Increased excretion of glycopeptides in the urine. Glycopeptides are peptides with carbohydrate moieties covalently attached to the side chains of the amino acid residues.] |